Peter Salzmann
2021
In 2021, Peter Salzmann earned a total compensation of $15.4M as Chief Executive Officer at Immunovant.
Compensation breakdown
| Bonus | $311,850 |
|---|---|
| Option Awards | $11,104,950 |
| Salary | $567,000 |
| Stock Awards | $3,252,500 |
| Other | $139,004 |
| Total | $15,375,304 |
Salzmann received $11.1M in option awards, accounting for 72% of the total pay in 2021.
Salzmann also received $311.9K in bonus, $567K in salary, $3.3M in stock awards and $139K in other compensation.
Rankings
In 2021, Peter Salzmann's compensation ranked 514th out of 12,406 executives tracked by ExecPay. In other words, Salzmann earned more than 95.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 514 out of 12,406 | 96th |
Division Manufacturing | 169 out of 5,492 | 97th |
Major group Chemicals And Allied Products | 50 out of 2,368 | 98th |
Industry group Drugs | 45 out of 2,089 | 98th |
Industry Biological Products, Except Diagnostic Substances | 18 out of 452 | 96th |
Source: SEC filing on June 30, 2022.